Results 331 to 339 of about 357,544 (339)

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial

Lancet, The, 2003
exaly  

Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial

Lancet, The, 2002
exaly  

PACLITAXEL

2004
openaire   +1 more source

Paclitaxel

Reactions Weekly, 1997
openaire   +1 more source

Relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): an open-label, randomised, controlled, phase 3 trial

Lancet, The
Bradley J Monk, Nicoletta Colombo, Giuseppe Caruso   +2 more
exaly  

Paclitaxel

Reactions Weekly, 1996
openaire   +1 more source

Treatment of HIV-associated Kaposi's sarcoma with paclitaxel

Lancet, The, 1995
exaly  

Paclitaxel hypersensitivity reactions related to bee-sting allergy

Lancet, The, 2000
exaly  

Paclitaxel

Oncology Times UK, 2012
openaire   +1 more source